Log in to save to my catalogue

Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment

Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2476739328

Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment

About this item

Full title

Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment

Publisher

London: Nature Publishing Group UK

Journal title

Nature reviews. Endocrinology, 2020-08, Vol.16 (8), p.437-447

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Glucocorticoids are widely used to suppress inflammation or the immune system. High doses and long-term use of glucocorticoids lead to an important and common iatrogenic complication, glucocorticoid-induced osteoporosis, in a substantial proportion of patients. Glucocorticoids mainly increase bone resorption during the initial phase (the first year...

Alternative Titles

Full title

Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2476739328

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2476739328

Other Identifiers

ISSN

1759-5029

E-ISSN

1759-5037

DOI

10.1038/s41574-020-0341-0

How to access this item